KARACHI: Initial results of a clinical trial conducted at the National Institute of Blood Diseases (NIBD) to assess the efficacy of plasma therapy in treating Covid-19 patients have showed over “80 per cent recovery rate”.

Patients were administered with plasma therapy at the stage of moderate to severe disease. The initial outcomes also conform to the results of similar ongoing trials across the world.

“It is quite heartening to see these initial trial results as they will eventually create enough evidence for doctors and scientists to overcome the threat posed by Covid-19,” said Dr Tahir Shamsi.

“We are extremely hopeful that plasma therapy may serve as a great breakthrough. This is an orthodox way of treatment used in other pandemics in the absence of a proven treatment.”

Published in Dawn, May 21st, 2020